Cumberland Tries To Shut Down Sagent's Generic Acetadote

Law360, Los Angeles (June 26, 2012, 9:58 PM EDT) -- Tennessee drugmaker Cumberland Pharmaceuticals Inc. launched a patent infringement suit in Delaware federal court Tuesday challenging an effort by Sagent Pharmaceuticals Inc. and Sagent Agila LLC to win U.S. regulatory approval for a generic version of acetaminophen-overdose treatment Acetadote.

Tuesday’s lawsuit is the second time in as many months that Cumberland has filed a patent infringement suit over attempts to market generic Acetadote, marking an aggressive push by the drugmaker to protect its patent on the injectable drug.

Cumberland claims the Sagent companies infringed its patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.